Tempus AI says 13 clinical research abstracts win ESMO 2026 presentation slots
TEM•Tempus AI said 13 cancer research abstracts were accepted for presentation at the ESMO Congress 2026 in Madrid, scheduled for Oct. 23-27.
1. Abstracts accepted
Tempus AI said 13 cancer research abstracts were accepted for the ESMO Congress 2026 in Madrid, with presentations scheduled for Oct. 23-27. The future presentations will use real-world multimodal data to examine differences in tumor biology, treatment response and outcomes across cancers including prostate, breast, non-small cell lung and ovarian cancer.
